Aventis Pharma’s Q4 net tumbles 66%

24 Feb 2012 Evaluate

Aventis Pharma’s net profit declined 65.58% to Rs 36.10 crore for the fourth quarter ended December 31, due to the acquisition of nutraceutical formulations business of Universal Medicare. The company had posted net profit of Rs 104.90 crore in the October-December period last year.

The company’s net sales rose to Rs 337.90 crore during the fourth quarter, as against Rs 286.50 crore in the same period previous year.

The profit for the quarter ended December 31, 2011 has been impacted due to the costs relating to the above acquisition and lower interest income as a result of the investment.

For the entire 2011, the company posted net profit of Rs 191.20 crore, as compared to Rs 230.70 crore in 2010. Net sales of the company for the year were Rs 1,229.70 crore, as against Rs 1,085 crore in 2010.

Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.